Search research articles
Contact Us
Filters
Showing results (1131-1140 of 1,270) with videos related to
Page
of 127
Sort By:
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, et al.
Iscience
|
August 25, 2021
InVision: An optimized tissue clearing approach for three-dimensional imaging and analysis of intact rodent eyes
Akshay Gurdita, Philip E B Nickerson, Neno T Pokrajac, et al.
Nucleic Acids Research
|
October 3, 2020
A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systems
Fintan K T Stanley, N Daniel Berger, Dustin D Pearson, et al.
Bone
|
October 9, 2024
microRNA-324 mediates bone homeostasis and the regulation of osteoblast and osteoclast differentiation and activity
Dan J Hayman, Francesca M Johnson de Sousa Brito, Hua Lin, et al.
Cancer
|
September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting
Julie R Park, Judith G Villablanca, Barbara Hero, et al.
Scientific Reports
|
April 20, 2022
Naloxone's dose-dependent displacement of [<sup>11</sup>C]carfentanil and duration of receptor occupancy in the rat brain
Yeona Kang, Kelly A O'Conor, Andrew C Kelleher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2013
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo
Jane Renshaw, Kathryn R Taylor, Ryan Bishop, et al.
The American Journal of Surgical Pathology
|
September 26, 2023
Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations
Catherine K Gestrich, Mathew P Vivero, Dennis J Konczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2022
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
Safa Majeed, Mansi K Aparnathi, Kevin C J Nixon, et al.
Nature
|
April 30, 2025
Cell cycle duration determines oncogenic transformation capacity
Danian Chen, Suying Lu, Katherine Huang, et al.
Page
of 127
Search research articles
Search
Showing results (1131-1140 of 1,270) with videos related to
Sort By:
Page
of 127
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, et al.
Iscience
|
August 25, 2021
InVision: An optimized tissue clearing approach for three-dimensional imaging and analysis of intact rodent eyes
Akshay Gurdita, Philip E B Nickerson, Neno T Pokrajac, et al.
Nucleic Acids Research
|
October 3, 2020
A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systems
Fintan K T Stanley, N Daniel Berger, Dustin D Pearson, et al.
Bone
|
October 9, 2024
microRNA-324 mediates bone homeostasis and the regulation of osteoblast and osteoclast differentiation and activity
Dan J Hayman, Francesca M Johnson de Sousa Brito, Hua Lin, et al.
Cancer
|
September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting
Julie R Park, Judith G Villablanca, Barbara Hero, et al.
Scientific Reports
|
April 20, 2022
Naloxone's dose-dependent displacement of [<sup>11</sup>C]carfentanil and duration of receptor occupancy in the rat brain
Yeona Kang, Kelly A O'Conor, Andrew C Kelleher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2013
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo
Jane Renshaw, Kathryn R Taylor, Ryan Bishop, et al.
The American Journal of Surgical Pathology
|
September 26, 2023
Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations
Catherine K Gestrich, Mathew P Vivero, Dennis J Konczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2022
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
Safa Majeed, Mansi K Aparnathi, Kevin C J Nixon, et al.
Nature
|
April 30, 2025
Cell cycle duration determines oncogenic transformation capacity
Danian Chen, Suying Lu, Katherine Huang, et al.
Page
of 127